Exenatide does not slow Parkinson’s disease progression compared to placebo
1. There was no significant difference in functional outcome between both groups at 96 weeks. 2. Exenatide was safe and ...
Tag: movement disorders
Genetic risk for hemochromatosis associated with abnormal iron deposition localized to motor circuits of the brain
1. This retrospective cross-sectional study found that among 836 individuals at high genetic risk for developing hemochromatosis, magnetic resource imaging ...
Adjuvant antipsychotic use in children treated for depression may be associated with movement disorders
1. This cohort study concluded that the concomitant use of antipsychotic and antidepressant medications in children was associated with movement ...